Search

everythinglearnresearchcommunity

for

Search:↓

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.

Telogen effluvium most affects quality of life in alopecia patients.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Vitamins and minerals don't significantly affect hair loss treatment in patients with telogen effluvium.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Sandalore® reduces hair shedding and increases hair volume in women with telogen effluvium.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Nutritional supplements can significantly reduce hair loss in telogen effluvium after three months.

Scalp treatments increased hair density and reduced hair loss in Telogen Effluvium patients.

Serum ferritin levels do not cause hair loss in women with telogen effluvium.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

The hairline-lowering surgery was effective, safe, and left patients satisfied with few complications.

Astragaloside IV may help prevent hair loss by blocking a specific pathway that leads to cell death.

Twisted hair is rare in severe anorexia nervosa, found in only 2 out of 30 patients.